Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study assessing safety, tolerability, and pharmacokinetics/pharmacodynamics of SNA02-48 Injection in Chin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• SNA02-48 Injection (SNA02-48)

Snippet

Sponsor: Sinovac Life Sciences Co., Ltd. | Conditions: Tetanus | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING